Dyadic International (DYAI) Assets (2017 - 2026)
Dyadic International (DYAI) posted Assets of $7.8 million for Q1 2026, down 21.48% sequentially from $9.9 million in Q4 2025, and down 1.08% YoY from $7.9 million in Q1 2025.
Dyadic International (DYAI) Assets (2017 - 2026) Analysis & Trends
Dyadic International has reported Assets for 10 years, with the latest figure at $7.8 million in Q1 2026.
- Quarterly Assets fell 1.08% year-over-year to $7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (down 1.08% YoY) and the FY2025 annual result came in at $9.9 million, changed 0.16% from the prior year.
- Assets slipped to $7.8 million in Q1 2026 per DYAI's latest filing, from $9.9 million in the prior quarter.
- Over five years, Assets peaked at $18.5 billion in Q1 2022 and troughed at $7.8 million in Q1 2026.
- A 5-year average of $1.1 billion and a median of $10.8 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2023: Assets soared 65419.07% in 2022, then slumped 99.93% in 2023.
- Over 5 years, Assets stood at $13.7 million in 2022, then plunged by 40.06% to $8.2 million in 2023, then grew by 20.82% to $9.9 million in 2024, then gained by 0.16% to $9.9 million in 2025, then declined by 21.48% to $7.8 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $7.8 million, $9.9 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | 7.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.81 Mn |
| Dec 31, 2025 | 9.95 Mn |
| Sep 30, 2025 | 11.67 Mn |
| Jun 30, 2025 | 8.14 Mn |
| Mar 31, 2025 | 7.89 Mn |
| Dec 31, 2024 | 9.93 Mn |
| Sep 30, 2024 | 10.81 Mn |
| Jun 30, 2024 | 10.63 Mn |
| Mar 31, 2024 | 12.68 Mn |
| Dec 31, 2023 | 8.22 Mn |
| Sep 30, 2023 | 9.26 Mn |
| Jun 30, 2023 | 11.07 Mn |
| Mar 31, 2023 | 12.81 Mn |
| Dec 31, 2022 | 13.71 Mn |
| Sep 30, 2022 | 15.22 Mn |
| Jun 30, 2022 | 17.22 Mn |
| Mar 31, 2022 | 18.53 Bn |
| Dec 31, 2021 | 21.30 Mn |
| Sep 30, 2021 | 23.86 Mn |
| Jun 30, 2021 | 26.45 Mn |